目的：分析我国中药追溯体系相关政策文本，探讨现有政策现状及倾向，为我国未来中药追溯体系政策制定及优化提供参考依据。方法：选取29份中药追溯体系相关政策为研究对象，采用内容分析法，基于政策工具及利益相关者2个维度进行分析。结果：政策工具维度中，命令与规制型、激励型、 能力建设型、系统变革型、信息与劝诫型工具分别占51.7%、12.2%、22.0%、1.0%、13.2%；利益相关者维度中，政府相关部门、中药生产企业、中药经营企业、医疗机构、消费者分别占45.2%、21.5%、 21.5%、6.3%、5.6%。结论：政策工具结构失衡，内部子工具使用不协调，利益相关者分布不均，应结合中药追溯体系相关政策特征及发展趋势，多元化使用政策工具，优化其内部结构，兼顾各利益相关方，增强主体凝聚力。

Objective: By analyzing the relevant policy texts on traditional Chinese medicine traceability system in China, this study discusses the current policy status and development tendency, which is aims to provide reference for formulation and optimization of traditional Chinese medicine traceability system policy in the future. Methods: Using the content analysis method, 29 policies related to traditional Chinese medicine traceability system were selected as research objects based on the two dimensions of policy tools and stakeholders. Results: In the dimension of policy tools, command and regulation, incentive, capacity building, system transformation, information and exhortation tools account for 51.7%, 12.2%, 22.0%, 1.0% and 13.2% respectively. In the dimension of stakeholders, relevant government departments, TCM production manufacturers, TCM distributors, medical institutions and consumers accounted for 45.2%, 21.5%, 21.5%, 6.3% and 5.6% respectively. Conclusion: The structure of policy tools is unbalanced, the use of internal policy tools is uncoordinated and the distribution of stakeholder is uneven. We should combine the relevant policy characteristics and development trends of the traditional Chinese medicine traceability system, use policy tools in a diversifi ed way, optimize its internal structure, take into account all stakeholders, and enhance the cohesion of the main body.